Dafang Wan

2.9k total citations
37 papers, 2.1k citations indexed

About

Dafang Wan is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Dafang Wan has authored 37 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 8 papers in Immunology and 8 papers in Cancer Research. Recurrent topics in Dafang Wan's work include RNA modifications and cancer (9 papers), Ubiquitin and proteasome pathways (7 papers) and RNA Research and Splicing (6 papers). Dafang Wan is often cited by papers focused on RNA modifications and cancer (9 papers), Ubiquitin and proteasome pathways (7 papers) and RNA Research and Splicing (6 papers). Dafang Wan collaborates with scholars based in China, United States and Sweden. Dafang Wan's co-authors include Jianren Gu, Jinjun Li, Ming Yao, Mingxia Yan, Chao Ge, Xianghuo He, Shengli Yang, Yingjun Zhao, Hu Chen and Haiyang Xie and has published in prestigious journals such as PLoS ONE, Nature Cell Biology and Analytical Chemistry.

In The Last Decade

Dafang Wan

37 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dafang Wan China 20 1.5k 703 569 229 207 37 2.1k
Xiaotong Hu China 24 1.0k 0.7× 416 0.6× 248 0.4× 68 0.3× 215 1.0× 82 1.7k
Sabina Cosulich United Kingdom 26 2.0k 1.3× 336 0.5× 526 0.9× 102 0.4× 234 1.1× 55 2.6k
Mark E. Schurdak United States 25 1.0k 0.7× 443 0.6× 182 0.3× 59 0.3× 129 0.6× 48 1.7k
Shanmugasundaram Ganapathy‐Kanniappan United States 20 1.4k 1.0× 1.2k 1.7× 321 0.6× 37 0.2× 221 1.1× 36 2.2k
Shujuan Shao China 23 1.3k 0.9× 690 1.0× 311 0.5× 44 0.2× 112 0.5× 61 1.8k
Hubert Lincet France 24 1.6k 1.1× 1.1k 1.6× 461 0.8× 60 0.3× 133 0.6× 35 2.3k
Feifei Xu China 24 1.2k 0.8× 352 0.5× 362 0.6× 137 0.6× 121 0.6× 76 1.8k
Saroj P. Mathupala United States 24 2.6k 1.8× 2.1k 3.0× 479 0.8× 51 0.2× 202 1.0× 32 3.6k
Yiding Chen China 21 975 0.7× 526 0.7× 710 1.2× 112 0.5× 69 0.3× 86 2.0k
Deguang Sun China 20 1.1k 0.7× 254 0.4× 223 0.4× 252 1.1× 91 0.4× 39 1.4k

Countries citing papers authored by Dafang Wan

Since Specialization
Citations

This map shows the geographic impact of Dafang Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dafang Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dafang Wan more than expected).

Fields of papers citing papers by Dafang Wan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dafang Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dafang Wan. The network helps show where Dafang Wan may publish in the future.

Co-authorship network of co-authors of Dafang Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Dafang Wan. A scholar is included among the top collaborators of Dafang Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dafang Wan. Dafang Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Mei, Ronghua Wu, Fuye Yang, et al.. (2013). Identification of FN1BP1 as a Novel Cell Cycle Regulator through Modulating G1 Checkpoint in Human Hepatocarcinoma Hep3B Cells. PLoS ONE. 8(2). e57574–e57574. 3 indexed citations
2.
Zhao, Yingjun, Xiaoying Wang, Tao Wang, et al.. (2010). Acetylcholinesterase, a key prognostic predictor for hepatocellular carcinoma, suppresses cell growth and induces chemosensitization. Hepatology. 53(2). 493–503. 81 indexed citations
3.
Ding, Jie, Shenglin Huang, Shun‐Quan Wu, et al.. (2010). Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA. Nature Cell Biology. 12(4). 390–399. 261 indexed citations
4.
Yin, Peiyuan, Dafang Wan, Chunxia Zhao, et al.. (2009). A metabonomic study of hepatitis B-induced liver cirrhosis and hepatocellular carcinoma by using RP-LC and HILIC coupled with mass spectrometry. Molecular BioSystems. 5(8). 868–876. 189 indexed citations
5.
Yao, Jian, Linhui Liang, Shenglin Huang, et al.. (2009). Microrna-30D Promotes Tumor Invasion and Metastasis by Targeting Galphai2 in Hepatocellular Carcinoma. Hepatology. 51(3). 846–856. 186 indexed citations
6.
Li, Jinjun, et al.. (2009). Role of hepatitis B surface antigen in the development of hepatocellular carcinoma: regulation of lymphoid enhancer-binding factor 1. Journal of Experimental & Clinical Cancer Research. 28(1). 58–58. 35 indexed citations
7.
Gao, Jin, Wenxi Li, Yunsheng Yuan, et al.. (2008). A protein–protein interaction network of transcription factors acting during liver cell proliferation. Genomics. 91(4). 347–355. 24 indexed citations
8.
Han, Guanghui, Mingliang Ye, Houjiang Zhou, et al.. (2008). Large‐scale phosphoproteome analysis of human liver tissue by enrichment and fractionation of phosphopeptides with strong anion exchange chromatography. PROTEOMICS. 8(7). 1346–1361. 169 indexed citations
9.
Wang, Yuan, Tao Wang, Xianzhe Shi, et al.. (2008). Analysis of acetylcholine, choline and butyrobetaine in human liver tissues by hydrophilic interaction liquid chromatography-tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 47(4-5). 870–875. 40 indexed citations
10.
11.
He, Xianghuo, et al.. (2008). Dysfunction of Murine Dendritic Cells Induced by Incubation with Tumor Cells. Cellular and Molecular Immunology. 5(2). 133–140. 5 indexed citations
13.
Guo, Ming‐Lei, Jinjun Li, Dafang Wan, & Jianren Gu. (2006). KIAA0101 (OEACT-1), an expressionally down-regulated and growth-inhibitory gene in human hepatocellular carcinoma. BMC Cancer. 6(1). 109–109. 26 indexed citations
14.
Zhang, Fengrui, Yujun Di, Jinjun Li, et al.. (2006). Molecular cloning and characterization of human Aph2 gene, involved in AP-1 regulation by interaction with JAB1. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1759(11-12). 514–525. 8 indexed citations
15.
Cheng, Jie, Dafang Wan, Jianren Gu, et al.. (2005). Establishment of a yeast system that stably expresses human cytochrome P450 reductase: Application for the study of drug metabolism of cytochrome P450s in vitro. Protein Expression and Purification. 47(2). 467–476. 19 indexed citations
16.
Ye, Xiaoxia, Hong Lü, Yao Yu, et al.. (2005). pp5644 Interacts with phosphatidylinositol-4-phosphate adaptor protein-1 associated protein-1. Molecular and Cellular Biochemistry. 271(1-2). 151–158. 6 indexed citations
17.
Pan, Dongning, Lin Wei, Ming Yao, Dafang Wan, & Jianren Gu. (2005). Down-regulation of CT120A by RNA interference suppresses lung cancer cells growth and sensitizes to ultraviolet-induced apoptosis. Cancer Letters. 235(1). 26–33. 9 indexed citations
18.
Shen, Li, Jian Hu, Hong Lü, et al.. (2003). The apoptosis‐associated protein BNIPL interacts with two cell proliferation‐related proteins, MIF and GFER. FEBS Letters. 540(1-3). 86–90. 28 indexed citations
19.
Wan, Dafang, Mei He, Junru Wang, et al.. (2003). Two variants of the human hepatocellular carcinoma‐associated HCAP1 gene and their effect on the growth of the human liver cancer cell line Hep3B. Genes Chromosomes and Cancer. 39(1). 48–58. 16 indexed citations
20.
Liu, Yongzhong, Jinjun Li, Fengrui Zhang, et al.. (2003). Molecular cloning and characterization of the human ASB-8 gene encoding a novel member of ankyrin repeat and SOCS box containing protein family. Biochemical and Biophysical Research Communications. 300(4). 972–979. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026